These findings prompt a reevaluation of Grem2's role in obesity and T2D, proposing that increased circulating Grem2 in obesity may act as a defensive response to counteract glucose homeostasis disturbances. The gene discussed is GREM2; the disease is type 2 diabetes mellitus.